5Yudkin JS,Panahlooa A,Stehouwer C,et al.The influence of improved glycaemic control with insulin and sulphonylureas on acute phase and endothelial markers in type Ⅱ diabetic subject[J].Diabetologia,2000,43(9):1099-1106.
6Pineda Torra I,Gervois P,Staels B.PPAR-α in metabolic disease,inflammation,atherosclerosis and aging[J].Curr Opinipidol,1999,10(2):151-159.
7Bloomgarden ZT.American Diabetes Annual Meeting,1999:insulin action and the development of type 2 diabetes[J].Diabetes Care,2000,23(2):248-252.
8Jeschke MG,Einspanier R,Klein D,et al.Insulin attenuates the systemic inflammatory response to thermal trauma[J].Mol Med,2002,8(8):443-450.
2Zwaka TP,Hombach V,Torzewski J.C-reactive protein-mediated low density lipoprotein uptake by macrophages implications for atherosclerosis[J].Circulation,2001,103:1194-1197
3Barzilay JI,Abraham L,Heckbert SR,et al.The relation of markers of inflammation to the development of glucose disorders in the elderly:the Cardiovascular Health Study[J].Diabetes,2001,50:2384-2389
4Pradhan AD,Manson JE,Rifai N,et al.C-reactive protein,interleukin 6,and risk of developing type 2 diabetes mellitus[J].JAMA,2001,286:327-334
5Sane T,Taskinen MR.Does familial hypertriglyceridemia predispose to NIDDM[J]?Diabetes Care,1993,16:1494-1501
6Fester A,D′Agostino RJr,Howard G,et al.Chronic subclinical inflammation as part of the insulin resistance syndrome[J].Circulation,2002,102:42-47.
7朱禧星.现代糖尿病学[M].上海:复旦大学出版社,2002.227.
8陈灏珠 李宗明.内科学[M].北京：人民卫生出版社,2001..
9Mojiminiyi OA,Abdella N,Moussa MA,et al.Association of C reactive protein with coronary heart disease risk factors in patients with type 2 diabetes mellitus[J].Diabetes Res Clin Pract,2002,58(1):37-44.
10Volanakis JE.Human C reactive protein:expression,structure,and function[J].Mol Immunol,2001,38(23):189-197.
6DelPrato S, Fehon AM, Munro N, et al. Improving glucose management: ten steps to get more patients with type 2 diabetes to glyeaemic goal [J].Int J Clin Pract,2005,59 ( 11 ) : 1345-1355.
7Blankenberg S,Rupprecht HJ,Poirier O,et al.Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease[J].Circulation,2003,107 (12):1579-1585.
8Cipollone F,lezzi A,Fazia M,et al.The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques:role of glycemic control[J].Circulation,2003,108 (9):1070-1077.
9Saito M,Ishimitsu T,Minami J,et al.Relations of plasma highsensitivity C-reactive protein to traditional cardiovascular risk factors[J].Atherosclerosis,2003,167 (1):73-79.
10Vozarova B,Weyer C,Lindsay RS,et al.High white blood cellcount is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes[J].Diabetes,2002,51 (2):455-461.
